Persistant and Recurrent Pneumonia
I. Definitions
- Persistent Pneumonia: Persistence of clinical symptoms or radiological shadows for > 4 weeks despite appropriate antibiotic therapy.
- Recurrent Pneumonia:
- 2 or more episodes in a single year, OR
- 3 or more episodes in a lifetime.
- Key Feature: There must be radiographic clearing between episodes.
II. Differential Diagnosis (Etiology)
The causes can be categorized based on the underlying mechanism.
A. Local/Anatomic Causes (Often focal recurrence)
- Intraluminal Obstruction:
- Foreign Body: Missed aspiration (Right lower lobe common).
- Endobronchial TB or tumors (rare).
- Extraluminal Compression:
- Vascular rings/slings.
- Enlarged lymph nodes (TB, Histoplasmosis).
- Congenital Malformations:
- Pulmonary Sequestration (recurrent infection in the sequestered lobe).
- Congenital Lobar Emphysema.
- Bronchogenic Cyst.
- Tracheobronchial stenosis.
B. Aspiration Syndromes
- Oropharyngeal Dysphagia: Cerebral Palsy, Bulbar palsy.
- Gastroesophageal Reflux (GERD): Severe reflux + microaspiration.
- H-type Tracheoesophageal Fistula: Presentation often delayed.
C. Generalized/Host Defense Defects (Often diffuse/multilobar)
- Cystic Fibrosis (CF): Most common genetic cause of suppurative lung disease.
- Primary Ciliary Dyskinesia (PCD): Recurrent pneumonia + Situs Inversus + Sinusitis (Kartagener syndrome).
- Immunodeficiency:
- Humoral: X-linked Agammaglobulinemia, Selective IgA deficiency.
- Cellular: HIV/AIDS, SCID.
- Phagocytic: Chronic Granulomatous Disease (CGD).
D. Specific Infections (Persistent)
- Tuberculosis: Always the first differential in endemic areas.
- Resistant Organisms: MRSA, Pseudomonas.
- Fungal: Aspergillosis, Histoplasmosis.
III. Diagnostic Approach
Step 1: Detailed History & Examination
- Choking history: Suspect Foreign Body.
- Site: Same lobe (Anatomic/FB) vs Different lobes (Immune/Aspiration).
- Associated features:
- Greasy stools/Failure to thrive
Cystic Fibrosis. - Ear discharge/Dextrocardia
PCD. - Feeding difficulties
Aspiration.
- Greasy stools/Failure to thrive
Step 2: Phase I Investigations (Basic)
- Complete Blood Count: Lymphopenia (Immune def), Neutropenia.
- Chest X-Ray: Compare with previous films to confirm persistence vs recurrence.
- Mantoux Test / IGRA: To rule out TB.
- Sweat Chloride Test: Gold Standard for Cystic Fibrosis (Should be done in ALL cases of recurrent pneumonia).
- Immunoglobulin Profile: IgG, IgM, IgA levels.
- HIV ELISA.
Step 3: Phase II Investigations (Anatomic/Functional)
- CT Scan Chest (CECT/HRCT):
- Defines bronchiectasis, sequestration, or lymphadenopathy.
- [Image of CT chest bronchiectasis]
- Flexible Bronchoscopy:
- Visualizes airway dynamics (malacia), foreign bodies, or compression.
- Bronchoalveolar Lavage (BAL): For culture and lipid-laden macrophages (aspiration).
Step 4: Phase III Investigations (Specific)
- Barium Swallow: For vascular rings/TEF/GERD.
- Nasal Nitric Oxide / Ciliary Biopsy: For PCD.
- NBT Test / DHR Flow Cytometry: For CGD.
IV. Management
A. General Principles
- Treat the Acute Episode: Culture-directed antibiotics.
- Nutritional Rehabilitation: High-protein, high-calorie diet.
- Airway Clearance: Chest physiotherapy and postural drainage (crucial for CF/PCD).
- Vaccination: Pneumococcal (PCV/PPSV23) and Influenza vaccines.
B. Specific Management (Treat the Cause)
| Etiology | Specific Management |
|---|---|
| Foreign Body | Rigid Bronchoscopy and removal. |
| Cystic Fibrosis | Nebulized saline/DNAse, Azithromycin, Creon enzymes, CFTR modulators. |
| Tuberculosis | Anti-tubercular therapy (ATT) as per weight bands. |
| Immune Deficiency | IVIG replacement (for humoral defects), prophylactic cotrimoxazole. |
| GERD | Thickened feeds, positioning, PPIs; Fundoplication if refractory. |
| Anatomic Defect | Surgical resection (e.g., Sequestration, Cyst). |
| Asthma | Inhaled Corticosteroids (ICS) β Asthma often mimics recurrent pneumonia (atelectasis misread as pneumonia). |
C. Follow-up
- Monitor growth velocity.
- Pulmonary Function Tests (PFTs) in older children.
- Repeat imaging only if clinical deterioration (ALARA principle).